National Research Corp Q3 revenue flat at $37.7M; EPS down to $0.33 from $0.38

NRC HEALTH

2022-Q3 EPS reported $1.00 revenue$113,424,000

Revenue $37.7M vs $37.8M prior year; net income $8.3M vs $9.7M; diluted EPS $0.33 vs $0.38.
CFO cited investments in innovation, marketing, and associate retention as margin headwinds.
Canadian operations phase-out and non-core decline offset core growth.
Paid $5.9M in dividends and $3.6M for share repurchases in Q3.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NRC HEALTH reported third quarter ended September 30, 2022 results: revenue $37.7 million, net income $8.3 million, EPS $0.33.

Period: third quarter ended September 30, 2022
Revenue: $37.7 million
Net income: $8.3 million
EPS: $0.33
Result: reported results

Exact text from the filing

Revenue for the third quarter ended September 30, 2022, was $37.7 million, compared to $37.8 million for the same quarter in 2021. Net income for the quarter ended September 30, 2022, was $8.3 million, compared to $9.7 million for the quarter ended September 30, 2021. Diluted earnings per share decreased to $0.33 for the quarter ended September 30, 2022, from diluted earnings per share of $0.38 for the quarter ended September 30, 2021.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

NRC HEALTH filing history →

Source: SEC EDGAR

accession 0001437749-22-025653

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.